Abstract
Phosphoinositide kinases such as PI3-kinase synthesize lipid second messengers that control diverse cellular processes. Recently, these enzymes have emerged as an important class of drug targets, and there is significant interest in discovering new lipid kinase inhibitors. We describe here a procedure for the high-throughput determination of lipid kinase inhibitor IC50 values. This assay exploits the fact that phosphoinositides, but not nucleotides such as ATP, bind irreversibly to nitrocellulose membranes. As a result, the radiolabeled lipids from a kinase assay can be isolated by spotting the crude reaction on a nitrocellulose membrane and then washing. We show that diverse phosphoinositide kinases can be assayed using this approach and outline how to perform the assay in 96-well plates. We also describe a MATLAB script that automates the data analysis. The complete procedure requires 3–4 h.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Katso, R. et al. Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu. Rev. Cell Dev. Biol. 17, 615–675 (2001).
Maehama, T. & Dixon, J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 273, 13375–13378 (1998).
Gupta, S. et al. Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. Cell 129, 957–968 (2007).
Rodriguez-Viciana, P. et al. Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell 89, 457–467 (1997).
Rodriguez-Viciana, P. et al. Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature 370, 527–532 (1994).
Samuels, Y. et al. High frequency of mutations of the PIK3CA gene in human cancers. Science 304, 554 (2004).
Karakas, B., Bachman, K.E. & Park, B.H. Mutation of the PIK3CA oncogene in human cancers. Br. J. Cancer 94, 455–459 (2006).
Chow, L.M. & Baker, S.J. PTEN function in normal and neoplastic growth. Cancer Lett. 241, 184–196 (2006).
Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943–1947 (1997).
Okkenhaug, K. et al. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice. Science 297, 1031–1034 (2002).
Ali, K. et al. Essential role for the p110delta phosphoinositide 3-kinase in the allergic response. Nature 431, 1007–1011 (2004).
Wymann, M.P. et al. Phosphoinositide 3-kinase gamma: a key modulator in inflammation and allergy. Biochem. Soc. Trans. 31, 275–280 (2003).
Hirsch, E. et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287, 1049–1053 (2000).
Camps, M. et al. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Nat. Med. 11, 924–955 (2005).
Barber, D.F. et al. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nat. Med. 11, 933–935 (2005).
Knight, Z.A. & Shokat, K.M. Chemically targeting the PI3K family. Biochem. Soc. Trans. 35, 245–249 (2007).
Gray, A., Olsson, H., Batty, I.H., Priganica, L. & Peter Downes, C. Nonradioactive methods for the assay of phosphoinositide 3-kinases and phosphoinositide phosphatases and selective detection of signaling lipids in cell and tissue extracts. Anal. Biochem. 313, 234–245 (2003).
Knight, Z.A. et al. A pharmacological map of the PI3-K family defines a role for p110alpha in insulin signaling. Cell 125, 733–747 (2006).
Knight, Z.A. et al. Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold. Bioorg. Med. Chem. 12, 4749–4759 (2004).
Balla, T. et al. Isolation and molecular cloning of wortmannin-sensitive bovine type III phosphatidylinositol 4-kinases. J. Biol. Chem. 272, 18358–18366 (1997).
Meyers, R. & Cantley, L.C. Cloning and characterization of a wortmannin-sensitive human phosphatidylinositol 4-kinase. J. Biol. Chem. 272, 4384–4390 (1997).
Nakagawa, T., Goto, K. & Kondo, H. Cloning and characterization of a 92 kDa soluble phosphatidylinositol 4-kinase. Biochem. J. 320 (Part 2): 643–649 (1996).
Nakagawa, T., Goto, K. & Kondo, H. Cloning, expression, and localization of 230-kDa phosphatidylinositol 4-kinase. J. Biol. Chem. 271, 12088–12094 (1996).
Ishihara, H. et al. Type I phosphatidylinositol-4-phosphate 5-kinases. Cloning of the third isoform and deletion/substitution analysis of members of this novel lipid kinase family. J. Biol. Chem. 273, 8741–8748 (1998).
Ishihara, H. et al. Cloning of cDNAs encoding two isoforms of 68-kDa type I phosphatidylinositol-4-phosphate 5-kinase. J. Biol. Chem. 271, 23611–23614 (1996).
Rameh, L.E., Tolias, K.F., Duckworth, B.C. & Cantley, L.C. A new pathway for synthesis of phosphatidylinositol-4,5-bisphosphate. Nature 390, 192–196 (1997).
Carpenter, C.L. et al. Purification and characterization of phosphoinositide 3-kinase from rat liver. J. Biol. Chem. 265, 19704–19711 (1990).
Knight, Z.A. & Shokat, K.M. Features of selective kinase inhibitors. Chem. Biol. 12, 621–637 (2005).
Cheng, Y. & Prusoff, W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099–3108 (1973).
Traut, T.W. Physiological concentrations of purines and pyrimidines. Mol. Cell. Biochem. 140, 1–22 (1994).
Gribble, F.M. et al. A novel method for measurement of submembrane ATP concentration. J. Biol. Chem. 275, 30046–30049 (2000).
Acknowledgements
Z.A.K. is a Howard Hughes Medical Institute Fellow of the Life Sciences Research Foundation. M.E.F. is an ARCS Foundation Fellow. We acknowledge funding from NIH training grant GM08284. K.M.S. received funding from the Howard Hughes Medical Institute. The research of T.B. and A.B. was supported by the Intramural Research Program of the National Institute of Child Health and Human Development of the National Institutes of Health. We thank James Hurley for the generous gift of PI(5)P4-KIIβ.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Knight, Z., Feldman, M., Balla, A. et al. A membrane capture assay for lipid kinase activity. Nat Protoc 2, 2459–2466 (2007). https://doi.org/10.1038/nprot.2007.361
Published:
Issue Date:
DOI: https://doi.org/10.1038/nprot.2007.361
This article is cited by
-
Autoimmune lymphoproliferative immunodeficiencies (ALPID) in childhood: breakdown of immune homeostasis and immune dysregulation
Molecular and Cellular Pediatrics (2023)
-
WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinoma
Nature Cancer (2023)
-
Novel phosphatidylinositol 4-kinases III beta (PI4KIIIβ) inhibitors discovered by virtual screening using free energy models
Journal of Computer-Aided Molecular Design (2020)
-
Direction of leukocyte polarization and migration by the phosphoinositide-transfer protein TIPE2
Nature Immunology (2017)
-
A cell cycle kinase with tandem sensory PAS domains integrates cell fate cues
Nature Communications (2016)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.